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AbSTRACT
Using an FLP/FRT‑based method to create germline clones, we screened Drosophila 
chromosome arms 2L and 3R for new female meiotic mutants. The screen was designed 
to recover mutants with severe effects on meiotic exchange and/or segregation. This 
screen yielded 11 new mutants, including six alleles of previously known meiotic genes 
(c(2)M and ald/mps1). The remaining five mutants appear to define at least four new 
genes whose ablation results in severe meiotic defects. Three of the novel meiotic mutants 
were identified at the molecular level. Two of these, mcm5A7 and tremF9, define roles in 
meiotic recombination, while a third, conaA12, is important for synaptonemal complex 
assembly. Surprisingly, five of the nine mutants for which the lesion has been identified 
at the molecular level are not the result of mutations characteristic of EMS mutagenesis, 
but rather due to the insertion of the transposable element Doc. This study demonstrates 
the utility of germline clone‑based screens for the discovery of strong meiotic mutants, 
including mutations in essential genes, and the use of molecular genetic techniques to 
map the loci.
INTRODuCTION
Genetic screens have been instrumental for the identification of genes involved in 
meiosis in Drosophila females.1-6 Screening for mutants that show meiotic defects has 
led to the discovery of numerous meiotic genes. Many of the meiotic mutants recovered 
through this type of approach appear to disrupt gene functions that are specific to meiosis 
(nod, ord, mei‑218, mei‑S332, mei‑S282, mei‑P22),1-4 while others are alleles of genes 
that also function in cellular or developmental processes in other tissues (mei‑9, mei‑41, 
mei‑352, CycE, mei‑P26, sub).2,4,6 In both cases, homozygous mutants are sufficiently 
viable and fertile for test crosses to reveal meiotic defects that are detected by analyzing 
the progeny that they produce. Most meiotic mutant screens used this strategy and thus 
required viable and fertile homozygous mutant females to screen for meiotic defects. 
Because of these requirements, the screens could not recover sterile or lethal mutants 
in genes whose products play essential roles in other tissues or developmental stages in 
 addition to their roles in meiosis.
FLP recombinase-mediated mitotic recombination7,8 has been used extensively in 
Drosophila to assess the functions of essential genes in both somatic and germline cells.9-12 
These techniques have also enabled genetic screens to reveal genes with functions that 
are otherwise masked by lethality earlier in development (reviewed in ref. 13). Screens of 
germline clones, in particular, have identified genes involved in oogenesis and embryonic 
pattern formation.14-17 Fedorova and colleagues5 performed a screen for meiotic mutants 
using a germline clone approach in females. However, only one of the recovered mutants 
was characterized for its effects on female meiosis.5,18
As described here, we further refined the process of screening for meiotic mutants using 
germline clones by both incorporating a Dominant Female Sterile (DFS) mutation into 
the screen, such that the only progeny that are recovered come from clones homozygous 
for the mutagenized arm (in our case 2L or 3R) and by mutagenizing chromosomes that 
carry the appropriate DNA polymorphisms to facilitate SNP mapping. The FLP-DFS 
system combines FLP/FRT with the use of the Dominant Female Sterile mutant ovoD1‑18 
to induce and select for mutant clones.9,11 Mutant clones produced by FLP-DFS are 
screened for meiotic defects through crosses to males that carry a compound autosome, in 
which progeny only arise if a compensating autosomal nondisjunction event occurs in the 
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female germline.8 This cross scheme has the advantages of selecting 
for strong meiotic mutants that experience a high frequency of 
nondisjunction and allowing stocks bearing putative meiotic mutants 
to be established from the cross progeny, which eliminates the need 
to create and maintain thousands of fly lines carrying mutagenized 
chromosomes. This efficiency is complemented by the choice of 
parental chromosomes that have been characterized for DNA poly-
morphisms such as insertion/deletion markers (InDels) and single 
nucleotide polymorphisms (SNPs) that facilitate the mapping and 
identification of the recovered mutants.19,20
In screens of chromosome arms 2L and 3R, we isolated eleven 
female meiotic mutants that have been mapped using molecular 
methods. Five are novel meiotic mutants in at least four genes not 
previously known to be involved in meiosis, and six are new alleles 
of two previously studied meiotic genes (two in c(2)M and four in 
ald/mps1). Three of the novel meiotic mutants were identified at 
the molecular level. One of these, mcm5A7, defines a role in meiotic 
recombination for a DNA replication protein Mcm5.21 The second 
mutant, tremF9, lies in a gene that encodes a previously uncharacterized 
zinc finger protein, while the third, conaA12, identifies a gene whose 
wild-type product is required for synaptonemal complex assembly. 
Surprisingly, five of the nine mutants for which the molecular lesion 
has been identified are associated with Doc transposable element 
insertions. In the case of two ald/mps1 alleles, the actual mutations 
were Doc insertions in the neighboring gene (CG18212) that may be 
exerting their effects through the cis-inactivation of ald.22
MATeRIALS AND MeTHODS
Drosophila stocks. Drosophila stocks and crosses were maintained 
on a standard yeast/cornmeal/corn syrup/malt extract/agar medium 
at 25°C, unless indicated otherwise. Descriptions of genetic 
markers and chromosomes can be found at http://www.flybase.
org/. Df(3R)LEP was constructed by FLP-mediated recombination 
essentially as described by Parks et al.23 using FRT sequences in 
PBac{RB}e04496 (FBti0041827) and P{XP}d01968 (FBti0054690), 
inserted at coordinates 14,191,845 and 14,222,824, respectively, on 
the chromosome 3R genome map (Release 5.1).
Alleles, deficiencies, transposon insertions, and aberrations used 
in this study:
ald1 (FBal0000408)
b (b1; FBal0000858)
B (B1; FBal0000817)
c(2)MEP2115 (FBal0121689)
c(3)G68 (FBal0001459)
car (car1; FBal0001541)
CG18212excision18
ci (ci1; FBal0001644)
cu1 (FBal0002131)
cv (cv1; FBal0002184)
es (FBal0003292)
eyR (FBal0003934)
f (f1; FBal0003944)
ncd1 (FBal0012910)
pr (pr1; FBal0013947)
rec2 (FBal0014515)
Sb1 (FBal0015145)
sc (sc1; FBal0015189)
st1 (FBal0016127)
Tb1 (FBal0016730)
v (v1; FBal0017656)
w1118 (FBal0018186)
y (y1; FBal0018607)
yd2 (FBal0117252)
y+ (FBal0190963)
Df(2L)r10 (FBab0001903)
Df(3R)AN6 (ref. 24)
Df(3R)BSC38 (FBab0036258)
Df(3R)Cha7 (FBab0002512)
Df(3R)DG2 (FBab0002519)
Df(3R)Dl‑BX12 (FBab0002534)
Df(3R)Exel6159 (FBab0038214)
Df(3R)Exel6178 (FBab0038233)
Df(3R)Exel7305 (FBab0038299)
Df(3R)fruw24 (FBab0026872)
Df(3R)H‑B79 (FBab0002586)
P{70FLP}3F (FBti0002716)
P{ald+} (Ref. 25)
P{EP}EP381 (FBti0007809)
P{ey‑FLP} (P{ey‑FLP.N}2; FBti0015982)
P{gc(2)M‑myc} (ref. 26)
P{ovoD1‑18}2La (FBti0002108)
P{ovoD1‑18}2Lb (FBti0002109)
P{ovoD1‑18}3R (FBti0002111)
P{SUPor‑P}CG18212KG08013 (FBti0024197)
P{XP}d01968 (FBti0054690)
P{y+}TPN1 (P{Car20y}TPN1; FBti0015795)
PBac{RB}e04496 (FBti0041827)
PBac{WH}f04903 (FBti0052057)
PBac{WH}f05981 (FBti0052677)
FRT40A (P{neoFRT}40A; FBti0002071)
FRT82B (P{neoFRT}82B; FBti0002074)
BSY (FBab0029200)
C(3)EN (FBab0000131)
C(2)EN (FBab0000106)
C(4)RM (FBab0000159)
CyO (FBba0000025)
TM3 (FBba0000047)
TM6B (FBba0000057)
TM6C (FBba0000071)
YSX • YL (FBab0010396)
Alleles, deficiencies, and transposon insertions generated in this 
study:
aldA15 (FBal0190500)
aldB4
aldB8
aldC3
c(2)M8C (FBal0191312)
c(2)M10C (FBal0191349)
conaA12
didyA6
mcm5A7
tremF9
Df(3R)LEP
Doc{}CG18212A15
Doc{}CG18212B8
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Doc{}c(2)M8C
Doc{}c(2)M10C
Doc{}conaA12
Germline clone screen for meiotic mutants. The same general 
strategy was used for screening chromosome arms 2L and 3R (Fig. 1). 
For 2L (Fig. 1B), y1 w1118 P{70FLP}3F/y1 w1118 P{70FLP}3F; 
FRT40A/FRT40A females were mutagenized (see below) with 
ethylmethanesulfonate (EMS) and crossed to P{ovoD1‑18}2La 
P{ovoD1‑18}2Lb FRT40A/CyO males. Similarly, for 3R (Fig. 1C), 
y1 w1118 P{70FLP}3F / y1 w1118 P{70FLP}3F; FRT82B / FRT82B 
females were mutagenized and crossed to w/Y; FRT82B P{ovoD1‑18}3R/
TM3, Sb1 males. The progeny of these crosses were heat shocked (see 
below) to induce FLP recombinase expression and germline clone 
formation. The resulting FRT40A */P{ovoD1‑18}2La P{ovoD1‑18}2Lb 
FRT40A and FRT82B */FRT82B P{ovoD1‑18}3R female progeny, 
which contain germline clones homozygous for the mutagenized 
chromosome arm (denoted by an asterisk [*]), were crossed to +/Y; 
C(3)EN, st1 cu1 es males when screening 2L, or +/Y; C(2)EN, b pr 
males when screening 3R. Males that carry a compound chromo-
some such as C(2)EN or C(3)EN produce sperm that are disomic or 
nullosomic for the corresponding autosome due to the attachment 
of the two autosome homologs in the compound chromosome.27-29 
If meiosis proceeds normally in the homozygous mutant clones, 
the resulting progeny will die as monosomic or trisomic embryos. 
Germline clones that are defective in meiosis and result in autosomal 
nondisjunction produce progeny that result from the fertilization of 
a disomic oocyte by a nullosomic sperm. Since they are heterozygous 
for the mutagenized chromosome, male progeny of this type were 
used to establish a stock containing the mutant chromosome for 
further analysis. Although not shown in Figure 1, fertilization of a 
nullosomic oocyte by a compound-bearing sperm will also result in 
progeny. However, these progeny were not used for stock establish-
ment because the compound chromosome would prohibit further 
analysis of the mutant.
After the initial isolation of each mutant, individual stocks 
were assessed for homozygous lethality or viability of the putative 
meiotic mutants, which were then tested in a secondary screen to 
confirm the presence of a meiotic phenotype by analyzing nondis-
junction frequency of the X and 4th chromosomes. Those that were 
 homozygous viable were assayed as homozygotes by crossing yd2 
Figure 1. Germline clone screens for female meiotic mutants. (A) Schematic diagram of germline clone screen on chromosome arm 2L for generating new 
EMS induced mutations and testing them for meiotic autosomal nondisjunction as germline clones. (B) Summary of crosses for the genetic screen to recover 
meiotic mutants on chromosome arm 2L. The mutagenized FRT40A chromosome is represented by an asterisk (*). (C) Summary of crosses for the genetic 
screen to recover meiotic mutants on chromosome arm 3R. The mutagenized FRT82B chromosome is represented by an asterisk (*).
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w1118 P{ey‑FLP}; FRT82B */FRT82B * virgin females obtained from 
the stocks to YSX • YL, v f B/0; C(4)RM, ci eyR males. Progeny from 
this cross were then scored for meiotic nondisjunction of the X and 
4th chromosomes (Table 1). For lethal mutants, we again generated 
females carrying homozygous mutant germline clones. For these 
mutants, yd2 w1118 P{ey‑FLP}; FRT82B */TM6B, P{y+}TPN1, Tb1 
virgin females were crossed to y1 w1118 P{70FLP}3F/Y; FRT82B 
P{ovoD1‑18}3R/TM6C, Sb1 males. The larval progeny were heat 
shocked (see below) to induce germline clone formation. Adult 
yd2 w1118 P{ey‑FLP}/y1 w1118 P{70FLP}3F; FRT82B */FRT82B 
P{ovoD1‑18}3R female progeny carrying homozygous mutant germ-
line clones were crossed to YSX • YL, v f B/0; C(4)RM, ci eyR males 
to produce progeny that were scored for meiotic nondisjunction 
(Table  1). Detailed methods for calculating X and 4th chromosome 
nondisjunction have been published elsewhere.30-32
Mutagenesis procedure. Virgin female y1 w1118 P{70FLP}3F/y1 
w1118 P{70FLP}3F; FRT40A/FRT40A or y1 w1118 P{70FLP}3F/y1 
w1118 P{70FLP}3F; FRT82B/FRT82B flies were starved for four 
hours in bottles lacking medium. Four Whatman #3 circular 
filter papers were taped to the bottom of empty 8 oz (240 ml) 
round-bottom polypropylene Drosophila bottles (Applied Scientific) 
and 4 ml of 25–35 mM EMS (Sigma) in 1% sucrose was added to 
the bottles. After the EMS/sucrose solution was absorbed by the 
filter papers, the starved flies were added to the bottles at a density 
of approximately 60–100 flies per bottle. The flies were then allowed 
to ingest the EMS/sucrose mixture for 24 hrs. After 24 hrs, the flies 
were transferred to bottles containing standard fly medium for an 
additional 24 hrs. The EMS-treated females were then transferred to 
fresh food bottles just prior to mating with males. Mutagenesis was 
performed on a weekly basis, and therefore multiple bottles of EMS 
were used throughout the screening process.
Heat‑shock procedure. For the generation of germline clones, 
five days after crossing adults, the adults were removed and the 
larvae were heat shocked to induce FLP expression. Heat shocks 
were applied to larvae in vials or bottles by immersion in a water 
bath set to 38°C for 1 hr. To ensure that larvae remained exposed to 
the water bath temperature, the rayon plug of each vial was pushed 
down to just above the surface of the medium, and the water level 
was adjusted to above the bottom of the plug. For bottles, the water 
level was adjusted up to the neck, and the bottle was held in place by 
a lead ring flask weight.
Molecular polymorphism mapping. Mutants recovered in the 3R 
screen were mapped to smaller regions of the chromosome arm by a 
strategy outlined by Berger et al.19 using molecular polymorphisms 
Table 1	 Segregation	in	mutants	recovered	from	a	germline	clone	screen	assayed	as	crosses	of	female	homozygotes	
or	homozygous	germline	clones	by	YSX • YL, v f B/0; C(4)RM, ci eyR/0	males
 Gamete Types
Maternal  Paternal conaA12	 aldA15	 aldB4	 aldB8	 aldC3	 mcm5A7b	 tremF9	 c(2)M8C	 c(2)M10C	 didyA6
X; 4 XY; 44 170 83 23 316 78 49 24 33 158 17
X; 4 0; 44 178 109 28 309 93 41 26 19 170 38
X ndj
0; 4 XY; 44 48 40 2 21 33 5 13 5 24 4
XX; 4 0; 44 45 39 4 6 17 10 10 5 18 3
4 ndj
X; 0 XY; 44 14 13 0 3 12 4 3 nd nd 1
X; 0 0; 44 14 5 2 3 10 1 0 nd nd 0
X; 44 XY; 0 nd nd nd nd nd nd nd nd nd nd
X; 44 0; 0 nd nd nd nd nd nd nd nd nd nd
X;4 ndj
0; 0 XY; 44 8 6 0 1 2 0 0 nd nd 0
XX; 44 0; 0 nd nd nd nd nd nd nd nd nd nd
0; 44 XY; 0 nd nd nd nd nd nd nd nd nd nd
XX; 0 0; 44 7 5 1 4 8 3 3 nd nd 0
Total progeny  484 300 60 663 253 113 79 62 370 63
Adjusted total  592 390 67 695 313 131 105 72 412 70
% X nondisjunction  36.49 46.15 20.9 9.21 38.34 27.48 49.52 27.78 20.39 20
% 4 nondisjunctiona  19.59 20.51 11.94 4.6 26.84 16.79 17.14 nd nd 2.86
% nullo‑X  18.92 23.59 5.97 6.33 22.36 7.63 24.76 13.89 11.65 11.43
% diplo‑X  17.57 22.56 14.93 2.88 15.97 19.85 24.76 13.89 8.74 8.57
% nullo‑4  9.8 10.26 5.97 2.3 13.42 8.4 8.57 nd nd 1.43
% diplo‑4  nd nd nd nd nd nd nd nd nd nd
Viability of mutation  viable viable lethalc viable lethalc viable viable viable viable nd
No./Type of females assayed 6/hom 5/hom 6/glc 15/glc 7/glc 5/glc 10/glc 9/glc 7/hom 9/glc
Abbreviations: nd, not determined; hom, assayed in homozygous females; glc, assayed in homozygous female germline clones. aBecause the females assayed were not homozygous for a recessive 4th chromosome marker 
spapol, diplo-4 progeny could not be scored, thus % 4 nondisjunction was estimated by doubling the frequency of nullo-4 gametes. bData from ref. 21. cRare escapers observed. 
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(InDels and SNPs). For 2L, a similar approach is available but 
was not used since both mutants recovered from 2L were alleles of 
c(2)M.
For each mutant to be mapped, yd2 w1118 P{ey‑FLP}; FRT82B 
*/TM6B, P{y+}TPN1, Tb1 females were crossed to yd2 w1118 
P{ey‑FLP}; P{EP}EP381 males to produce yd2 w1118 P{ey‑FLP}; 
FRT82B */P{EP}EP381 females. These females were crossed to yd2 
w1118 P{ey‑FLP}; FRT82B males to generate recombinant progeny. 
Male progeny carrying recombinants between the FRT82B * chro-
mosome and P{EP}EP381 were detected by pigmented eye clones 
resulting from FLP expression in the eye and the mini‑w+ gene 
carried by P{EP}EP381. Males carrying recombinant chromosomes 
were collected and separately crossed to establish stocks.
Lysates made from single FRT82B P{EP}EP381 recombinant/
TM6B, P{y+}TPN1, Tb1 flies33 were subjected to PCR to geno-
type InDel markers using an amplification fragment length assay 
(Supplementary Material Table S1).19-20 Further information on 
the molecular polymorphisms can be found at The FlySNP Project 
website (http://flysnp.imp.ac.at/index.php). For each marker, the 
reactions contained three oligonucleotide primers: one primer 
contained a T7 sequence at the 5' end and sequence specific to one 
side of the InDel at the 3' end, the second primer corresponded to 
sequence flanking the other side of the InDel, and the third primer 
was a T7 primer that was 5'-labeled with the fluorophore 6-FAM 
(Supplementary Material Table S1). After the reaction, PCR product 
sizes were detected using a 3730 DNA Analyzer and GeneMapper 
software (Applied Biosystems, Foster City, CA). Control reactions 
established the allele sizes on the parental FRT82B and P{EP}EP381 
chromosomes, as well as TM6B, P{y+}TPN1, Tb1 for each InDel.
Recombinant lines were genotyped for SNPs by sequencing. 
Lysate DNA was amplified by PCR using primers flanking the 
SNPs (Supplementary Material Table S2). The PCR products were 
then purified and sequenced from both ends using the amplifica-
tion primers. The sequence data was analyzed using Mutation 
Surveyor software (Softgenetics, State College, PA) to determine SNP 
 genotypes (Supplementary Material Table S3).
Selected recombinants were tested for presence of the mutation by 
a genetic assay for X chromosome nondisjunction. Recombinants that 
were homozygous viable were tested by crossing back to the original 
mutant stock to generate recombinant / FRT * females. Recombinants 
that were lethal were tested by crossing to y1 w1118 P{70FLP}3F/Y; 
FRT82B P{ovoD1‑18}3R/TM3, Sb1 males and generating germline 
clones. Comparison of genotypes with phenotype data allowed the 
meiotic mutant to be mapped.
In parallel with InDel/SNP mapping, several of the mutants were 
mapped by testing for complementation of the meiotic nondisjunc-
tion phenotype using deficiencies obtained from the Bloomington 
Drosophila Stock Center (http://flystocks.bio.indiana.edu/).
Immunolocalization. Immunofluorescence on ovarioles was 
performed essentially as described previously.34 The primary 
 antibody used was mouse monoclonal anti-C(3)G 1A8 (1:500).35 
The secondary antibody was Alexa 568 anti-mouse IgG (1:500) 
(Invitrogen, Carlsbad, CA). Microscopy was conducted using a 
DeltaVision microscopy system (Applied Precision, Issaquah, WA) 
equipped with an Olympus IX70 inverted microscope and CoolSnap 
CCD camera. Z-stacks of wide-field fluorescence images were 
collected at 0.2 mm intervals. Image stacks were deconvolved using 
the SoftWoRx v.2.5 software (Applied Precision).
ReSuLTS
A germline clone screen for meiotic mutations. We have used 
a strategy based on germline clones to screen for mutants in genes 
that function in female meiosis. This approach has the potential to 
 identify genes that also have an essential role early in development 
and cause lethality when mutated. In the design of the screen, we 
generated females carrying homozygous mutant germline clones 
via the FLP-DFS technique.9-11 As shown in Figure 1, only eggs 
that carry zero or two copies of a given autosome will survive when 
fertilized by sperm produced by compound autosome-bearing males. 
The ability of a given clone to produce a substantial number of such 
progeny is indicative of high levels of nondisjunction, as might be 
expected if that clone were homozygous for a strong meiotic mutant. 
In this scheme females carrying a second chromosome bearing an 
FRT site on 2L were crossed to males bearing a compound 3 chromo-
some and females carrying a third chromosome bearing an FRT site 
on 3R were crossed to males bearing a compound 2 chromosome.
Thus, fertile male progeny that did not carry the compound 
chromosome, but which were heterozygous for the mutagenized 
chromosome, were used to establish stocks, each of which were 
retested in search of a novel meiotic mutant. The screen was initially 
conducted on autosomal chromosome arms 2L and 3R, which 
together comprise approximately 42% of the Drosophila genome. In 
the 2L screen, 20,817 chromosome arms were screened and 25,571 
chromosome arms were screened for 3R. We established 36 indepen-
dent stocks of putative meiotic mutants on 2L and 35 independent 
stocks of putative 3R meiotic mutants.
The putative meiotic mutants were assessed for homozygous 
lethality or viability prior to testing in a secondary screen for meiotic 
nondisjunction to confirm the presence of a meiotic mutant. The 
majority of the putative mutants (59/71) showed low levels (less than 
2%) or no X nondisjunction. These probably represented progeny 
from the original cross that arose through spontaneous nondisjunc-
tion events and did not carry a meiotic mutant. One of the remaining 
twelve lines did retest in terms of exhibiting elevated levels of nondis-
junction, but repeated attempts to map the lesion causing this defect 
have been unsuccessful. We think it likely that this meiotic mutant 
is synthetic, and it was not characterized further. The eleven mutants 
detailed in this manuscript include two mutants on chromosome 
arm 2L and nine mutants on 3R that displayed elevated levels of X 
nondisjunction, ranging from 9.2 to 49.5% (Table 1). These most 
likely represent mutations affecting meiosis.
To ascertain whether we had recovered new alleles of previously 
characterized meiotic genes, we performed complementation tests 
with known meiotic mutants located on chromosome arms 2L 
or 3R. The mutants on 2L were tested for complementation 
with c(2)MEP2115, located at polytene band 35F7.36 Mutants on 
3R were tested for complementation with c(3)G68 at 89A5,34,37 
recombination‑defective (rec2) at 89A5,38,39 altered disjunction (ald1) 
at 90C1,25,40 and non‑claret disjunctional (ncd1) at 99C1-2.41 Both 
mutants recovered in the 2L screen failed to complement c(2)MEP2115 
and four of the 3R mutants failed to complement ald1. For each of 
these six mutants we have characterized the mutation. These results 
indicated that this screen strategy can indeed recover mutants that 
affect genes involved in meiosis. In the case of ald, we recovered two 
lethal alleles, aldC3 and aldB4, which would not have been found had 
the screen required testing viable homozygous mutant females.
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Five of the mutants on 3R fully complemented c(3)G68, rec2, 
ald1 and ncd1, suggesting that they may identify novel genes whose 
products are required for meiosis. We refer to four of these mutants as 
corona (cona), minichromosome maintenance 5 (mcm5), trade embargo 
(trem), and disjunction dysfunction (didy). Of these mutants, two 
(conaA12 and mcm5A7) were homozygous viable, and two (tremF9 and 
didyA6) carried unrelated lethals on 3R. The one remaining meiotic 
mutant was phenotypically identical to didy (see below), and there-
fore will remain nameless until it is determined whether these two 
mutants are allelic. For conaA12, mcm5A7, and tremF9, we have identi-
fied both the affected gene and the molecular lesion. Surprisingly, of 
the nine mutants recovered in the screen for which we have identified 
the mutation, five were shown to be the result of the insertion of a 
Doc retrotransposon.42,43 Three of the remaining mutants carried 
point mutations and one was an intragenic deletion.
Mutants recovered on 3R. Four new alleles of Ald. We recovered 
four mutants (aldA15, aldB4, aldB8 and aldC3) that fell into a single 
complementation group and caused from 9 to 46% X chromo-
some nondisjunction (Table 1). Using the molecular polymorphism 
mapping strategy (see Materials and Methods), all four mapped to 
intervals that overlapped between 90C1 and 90E1, which includes 
the Drosophila mps1 homolog, ald. Each of the mutants failed to 
complement the meiotic phenotype of the ald1 allele and could be 
rescued by the presence of the P{ald+} construct (data not shown), 
which contains a functional copy of ald+.25
Sequencing of aldB4 and aldC3 revealed a lesion in ald for each 
mutant; aldB4 was found to have an early C to T nonsense muta-
tion that changes glutamine at position 48 to a stop codon, while 
aldC3 has a 27 bp deletion that deletes amino acids 369–377 
(DLQADPQVV) from the kinase domain of the protein. aldC3 and 
aldB4 are lethal as homozygotes but permit rare escapers, a phenotype 
similar to other severe alleles of ald44 that could also be rescued by 
the presence of P{ald+}.
In contrast to aldB4 and aldC3, sequencing of aldA15 and aldB8 
showed no nucleotide changes in the ald transcription unit compared 
to the background stock. Further experiments revealed that a Doc 
non-LTR transposable element42,43 had inserted in the neighboring 
gene (CG18212) downstream of ald in each of these two mutants. 
The insertion in aldA15, Doc{}CG18212A15, is located 1607 bp from 
the 3' end of the ald transcript and in aldB8, Doc{}CG18212B8 is 
located 2042 bp from the 3' end of the ald transcript. This is a 
paradoxical result in that aldA15 and aldB8 fail to complement ald1 
and are rescued by the P{ald+} transgene, but the only lesions found 
are located in a neighboring gene (CG18212), outside the genomic 
region included in the P{ald+} transgene.22
Additional evidence strongly suggests that the phenotypes of 
aldA15 and aldB8 result from effects on the function of the ald gene 
rather than CG18212. CG18212excision18, an imprecise excision of 
P{SUPor‑P}CG18212KG08013 that deletes ~90% of the CG18212 
coding sequence, including the insertion sites of both Doc elements, 
complements the meiotic nondisjunction phenotype of these alleles, 
indicating that loss of CG18212 is not responsible for the meiotic 
phenotype. Conversely, a different imprecise excision of P{SUPor‑P}
CG18212KG08013, Df(3R)AN6, which deletes CG18212 and almost 
the entire ald locus, fails to complement aldA15 and aldB8 (data not 
shown). Thus, the Doc elements inserted in CG18212 appear to 
specifically affect ald function. The Doc elements in aldA15 and aldB8 
may be exerting effects in cis on the expression of the neighboring ald 
gene in the female germline.22 The ability for transposable elements 
to exert cis-acting effects on the expression of neighboring genes 
is well known.45-49 Moreover, fragments of non-LTR transposons 
closely related to Doc elements can mediate gene silencing in the 
female germline.50 A cis-acting effect of the Doc elements on ald 
expression in the germline is consistent with the observation that 
aldA15 and aldB8 show meiotic defects but do not appear to affect the 
mitotic function of ald.22
A meiotic function for mcm5. Among the mutants recovered in 
the screen of 3R was one that produced 27.48% X nondisjunction 
and 16.79% 4th nondisjunction (Table 1). Molecular polymorphism 
mapping localized the mutation to the region 85B3-87C7. The 
mutant was further mapped to the interval 86C6-86C7 by non-
complementation with the deficiencies Df(3R)BSC38 (85F1;86C8), 
Df(3R)Exel6159 (86C3;86C7) and Df(3R)Exel7305 (86C6;86C7). 
Within the interval of approximately 17 kb defined by these deficien-
cies is the Drosophila minichromosome maintenance 5 (mcm5) gene. 
Mcm5 is one of a conserved family of proteins that are required for 
DNA replication.51 Sequencing of the mcm5 gene in the mutant 
revealed a single missense AgT transversion (A2081T) in the first 
codon of the last exon, which results in the change of an aspartic 
acid residue to valine (D694V). To verify that the segregation defects 
observed were indeed the consequence of this mutation, we tested 
whether the phenotype could be rescued using a transgenic construct 
that expresses wild-type Mcm5 from its own genomic promoter or 
a construct expressing wild-type Mcm5 from a germline-specific 
promoter. Both of these constructs fully suppressed the meiotic 
phenotype of mcm5A7.21
We reasoned that a mutation in mcm5 could possibly affect meiotic 
recombination. Assays for meiotic crossing over in mcm5A7 homozy-
gotes revealed a 90% decrease in crossover frequency (Table 2), 
although C(3)G localization appears normal.21 These results indicate 
that mcm5A7 is defective in the pathway of meiotic recombination. A 
fuller description of this mutant, in the context of a thorough genetic 
dissection of the mcm5 gene has recently been published.21
Corona, a novel mutant that disrupts crossing over. We recovered 
a single allele (conaA12) of a novel gene required for proper synapto-
nemal complex formation that we have named corona (cona). The 
conaA12 mutant is viable and displayed frequencies of X and 4th 
chromosomal nondisjunction of 36.5% and 19.6%, respectively. The 
conaA12 mutant was shown by molecular polymorphism mapping to 
lie between InDel marker 3R092 and SNP marker 3R118, a region 
spanning 89F3 to 91B2. Deficiencies within the genetically mapped 
interval, Df(3R)DG2 and Df(3R)Cha7, failed to complement conaA12, 
thus further refining the position of cona to the interval 90F1-91B2. 
This mapping was further refined to 91A1-91A5 by non-comple-
mentation of conaA12 with Df(3R)Exel6178 and Df(3R)fruw24, and 
finally to a molecularly defined 31 kb interval by failure to comple-
ment a newly constructed deficiency, Df(3R)LEP.
One transposon insertion in the 31 kb interval, PBac{WH}f04903, 
failed to complement conaA12, and thus represents a second allele, 
called conaf04903. PBac{WH}f04903 is a PiggyBac insertion located in 
the region flanking the 5’ end of the gene CG7676, which suggested 
that a mutation in CG7676 could be present in conaA12. The 
CG7676 locus on the conaA12 chromosome was sequenced, revealing 
no base changes within the protein-coding region. However, an 
insertional mutation was detected in the 3' untranslated region 
of CG7676 between the stop codon and the polyA signal. Inverse 
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PCR experiments led to the identification of the insertion as a Doc 
element that was not present on the FRT82B chromosome used 
in the screen. The presence of the insertion within the CG7676 3' 
untranslated region in conaA12, and the failure of PBac{WH}f04903 
to complement conaA12 strongly implicates CG7676 as the defective 
gene resulting in the cona meiotic phenotype. The CG7676/cona 
gene is comprised of four exons separated by short introns. Based on 
cDNA sequencing, cona encodes a previously uncharacterized 207 
amino acid protein. The Cona protein shows no strong homologies 
to other proteins or protein motifs except for orthologs in other 
Drosophila species.
To further investigate the meiotic phenotype of cona, we analyzed 
crossing over and SC formation in females homozygous for the original 
conaA12 allele or a second allele, conaf04903. In wild-type controls, the 
X chromosome genetic map length from sc to 
the centromere was 70.7 cM (n = 2505). In 
contrast, crossover frequency is reduced 50-200 
fold in cona homozygotes, to 0.4 cM for conaA12 
(n = 821) and 1.4 cM for conaf04903 (n = 1174) 
(Table 2). This severe effect on meiotic recom-
bination could be due to a deficiency of a 
 recombination-specific function or result from 
a defect in SC formation. To test whether Cona 
could be important for the formation and/or 
function of the SC, we investigated whether 
C(3)G is able to localize normally in the absence 
of wild-type cona. The C(3)G protein is a compo-
nent of the transverse filaments of the SC34,35 
and forms a thread-like pattern of immunolo-
calization within pro-oocyte nuclei (Fig. 2A–C). 
In conaf04903 or conaA12 homozygotes, however, 
this pattern is severely disrupted (Fig. 2D–F). 
In contrast to the thread-like signals that are 
associated with concentrations of chromatin 
in wild-type pro-oocytes, C(3)G is observed in 
amorphous plaque-like structures that tend to 
be excluded from concentrations of chromatin 
within the nucleus, suggesting that the SC is not 
formed correctly. These data demonstrate that 
Cona provides a function crucial for proper SC 
formation and meiotic recombination. Further 
studies of the function of Cona will be described 
in a future manuscript.
Trade embargo, a novel recombination 
 defective meiotic mutant. One of the strongest 
mutants isolated in the screen, which we have 
named trade embargo (trem), demonstrated 
49.5% X nondisjunction upon initial testing in 
germline clones among a low number of progeny. 
Molecular polymorphism mapping using InDel 
and SNP markers localized the tremF9 mutation 
to between markers 3R130 and 3R160 (92A2–
93E4). Deficiencies in this region were then used 
to perform complementation tests, which revealed 
that the overlapping deficiencies Df(3R)Dl‑BX12 
(91F1-2;92D3-6) and Df(3R)H‑B79 (92B3; 
92F13) uncovered the mutation. This narrowed 
the interval containing tremF9 to the region of 
overlap between these deficiencies, 92B3-92D6. Among a number of 
insertion mutations that map within this region, PBac{WH}f05981 
failed to complement tremF9. PBac{WH}f05981 is inserted 55 bp 
upstream of the start codon of CG4413, thus implicating CG4413 
as being mutated in tremF9. Sequence analysis of CG4413 in tremF9 
showed a C to T point mutation that was not present on the parental 
chromosome.
The protein encoded by CG4413 contains a zinc finger-associated 
C4DM domain (ZAD) and a C-terminal series of five C2H2 zinc 
fingers.52 The tremF9 mutation changes proline 299 to a leucine 
residue in the conserved linker sequence between the first and second 
zinc fingers. Zinc finger linker sequences are well conserved but 
their exact role in protein function is not fully known.53 However, 
 mutational analyses have revealed a role for linker sequences in 
Table 2	 Results	of	crosses	of	females	of	the	genotype	y sc cv v f · y+/
y + + + +;	3/3	carrying	the	indicated	chromosomes 3	by	y sc cv v f 
car/BSY	malesa
      	X Chromosome Interval   Frequency of  
       Oocytes that   
 sc‑cv	 cv‑v	 	 v‑f	 f‑y+ Total Map Did Not undergo   
      Length (cM) X exchange (eo) N
wild‑type 14.6 20.2 21.8 14.1 70.7 0.07 2505
mcm5A7b 1.0 1.3 1.5 2.5 6.9 0.88 875
tremF9 0.7 3.4 1.7 1.4 7.2 0.86 2297
conaA12 0.0 0.0 0.0 0.4 0.4 0.99 821
conaf04903 0.1 0.1 0.1 1.1 1.4 0.97 1174
didyA6 10.4 9.0 26.0 14.0 59.4 0.08 299
aFemale progeny were scored.34 bData from ref. 21.
Figure 2. corona is required for the proper localization of the synaptonemal complex protein 
C(3)G. (A–C) C(3)G localizes in a thread‑like pattern in wild type. (A) C(3)G (red), (B) DAPI 
(cyan), (C) merge of (A) and (B). (D–F) C(3)G localization is abnormal in conaf04903 homozygotes, 
with an amorphous, plaque‑like appearance that is excluded from concentrations of chromatin. An 
identical phenotype is observed in conaA12 homozygotes (not shown). (D) C(3)G (red), (E) DAPI 
(cyan), (F) merge of (D and E). All panels are single deconvolved optical sections. Scale bar, 1 
mm.
www.landesbioscience.com Fly 179
A Germline Clone Screen for New Meiotic Mutants
promoting DNA binding in at least some zinc finger proteins.53-58 
Many zinc finger proteins are able to bind DNA and act as 
 transcription factors, although it is intriguing to speculate that Trem 
could interact with DNA during the process of recombination. We 
therefore tested the frequency of recombination of tremF9 homozy-
gotes. tremF9 displays a 90-fold decrease in the total frequency of 
crossing over (Table 2). This decrease in recombination was not due 
to the failure to form proper SC, in that C(3)G localization appeared 
normal in tremF9 homozygotes (data not shown). The function of 
Trem and the affect it has on recombination will be discussed in a 
future manuscript.
Disjunction dysfunction (didy), a novel meiotic mutant that does 
not alter SC formation or recombination frequency. Germline 
clones homozygous for the didyA6 mutant produce few progeny, but 
demonstrate a rate of 20% X nondisjunction (Table 1). Mapping of 
didyA6 using molecular polymorphisms places it within the interval 
94C1 to 99E1. Although the gene has not yet been identified, we 
have analyzed SC formation and meiotic recombination in didyA6 
germline clones. We did not detect a defect in SC formation (data 
not shown) or an altered recombination frequency (Table 2).
Another mutant recovered from the screen was phenotypically 
similar to didyA6. This mutant maps to the same interval (94C1-99E1), 
displays poor fertility, normal SC and had no affect on recombina-
tion (data not shown). However, it displays a lower frequency of X 
nondisjunction than didyA6, at approximately 11%. In addition, both 
chromosomes apparently bear noncomplementing lethal mutations, 
and therefore, we could not assess the meiotic phenotype in 
trans-heterozygotes. For these reasons, it remains possible that these 
two mutants define the same gene.
Mutants recovered on 2L. New alleles of c(2)M. Two meiotic 
mutants were recovered from the screen of chromosome arm 2L and 
both are alleles of c(2)M, called c(2)M8C and c(2)M10C. As a homo-
zygote, c(2)M10C is viable and displays 20.39% X nondisjunction. 
c(2)M8C carries an unlinked lethal mutation on chromosome 2. When 
assayed in germline clones, c(2)M8C shows 27.78% X nondisjunction. 
The c(2)M8C and c(2)M10C alleles fail to complement each other and 
fail to complement both c(2)MEP2115 and a deficiency for the c(2)M 
locus, Df(2L)r10. We attempted to determine whether the c(2)M 
gene carried mutations in c(2)M8C and c(2)M10C by amplifying and 
sequencing c(2)M. Each allele contained a segment of the c(2)M 
coding region that repeatedly failed to amplify from template DNA 
isolated from homozygous or hemizygous individuals. Inverse PCR 
was then employed to determine whether a DNA rearrangement 
had occurred. In both alleles, a Doc retrotransposon was found to 
have inserted into the c(2)M gene. The Doc element in c(2)M8C 
was inserted in exon 2 in the opposite 5'–3'orientation compared to 
the gene. In c(2)M10C, a Doc element was located in exon 4 in the 
same 5’-3’ orientation as the gene. Both insertions were into protein 
coding sequence and thus would be expected to severely disrupt the 
production of functional C(2)M protein.
To confirm that the lesions in c(2)M were responsible for the 
meiotic phenotype observed in these alleles, we asked whether the 
defects in c(2)M8C and c(2)M10C could be rescued by a wild-type copy 
of the c(2)M gene. For these experiments, we utilized P{gc(2)M‑myc}, 
a transgene that produces myc epitope-tagged C(2)M under the 
control of the c(2)M promoter.26 These experiments demonstrated 
that the presence of P{gc(2)M‑myc} could ameliorate the nondisjunc-
tion phenotypes of both c(2)M8C and c(2)M10C (Table 3).
Mutation of c(2)M is known to disrupt the localization of the 
synaptonemal complex protein C(3)G.36 C(3)G protein localization 
in c(2)M10C homozygous ovaries was found to be defective, with 
only punctate sites of localization along chromosomes in meiotic 
prophase nuclei (data not shown), which resembles the phenotype 
of c(2)MEP2115.36
DISCuSSION
Screening for meiotic mutants in germline clones. This study 
demonstrates the utility of germline clone screens to isolate novel 
mutants affecting female meiosis and also the efficacy of molecular 
mapping methods based on SNP and InDel polymorphisms to 
quickly identify the genes defined by those mutations. We have taken 
a clonal approach to identify novel mutants affecting female meiosis 
because it allows the successful recovery of both lethal and viable 
mutants. This differs from previous screens, which could only recover 
mutations in genes that are not essential for viability.
Our approach combines three key features to facilitate the rapid 
isolation and identification of new meiotic mutants. First, the 
FLP-DFS technique9,11 is used for the generation of germline clones 
homozygous for entire chromosome arms while simultaneously 
blocking oogenesis in nonrecombinant and twin-spot clones using 
the dominant female sterile ovoD1‑18 mutation carried on P element 
insertions.59 Second, females bearing germline clones are mated with 
males carrying either C(2)EN or C(3)EN. The generation of nullo-2 
or nullo-3 sperm by these males27-29 allows oocytes in which nondis-
junction of the corresponding autosome has occurred during female 
meiosis to survive. Moreover, crossing these females to compound 
autosome-bearing males also eliminates normal meiotic products 
as lethal monosomic or trisomic zygotes. Third, we utilized InDels 
and SNPs to rapidly map the recovered mutants.19,20 This genetic 
mapping approach allows the meiotic phenotype to be assayed, 
whereas lethals, if also present, would confound mapping based 
only on deficiencies. Overall, the screen is quite stringent, requiring 
several conditions to be met for mutant recovery (germline clone 
formation, nondisjunction, gametic complementation), which results 
in selection for strong meiotic phenotypes, such as those observed in 
cona A12, trem F9 and ald C3 (Table 1).
Table 3	 Nondisjunction	phenotypea	and	phenotypic		
rescue	of	new	alleles	of	c(2)M
Genotypeb % X  Adjusted  
 Nondisjunction Total
c(2)M8C/c(2)M8C [c] 27.78 72
c(2)M8C/c(2)MEP2115 22.02 981
c(2)M8C/Df(2L)r10 33.15 1047
c(2)M8C/c(2)M8C; P{gc(2)M-myc}/+ [c] 0.0 520
c(2)M8C/c(2)M10C 20.70 860
c(2)M10C/c(2)M10C 20.39 412
c(2)M10C/c(2)MEP2115 22.15 1616
c(2)M10C/Df(2L)r10 32.92 565
c(2)M10C/c(2)M10C; P{gc(2)M-myc}/+ 0.38 2099
c(2)M10C/c(2)M10C 20.39 412
aResults of crosses of females of the indicated genotypes by YSX · YL, v f B/0; C(4)RM, ci ey
R/0 males. bFull 
genotype not shown. cNondisjunction assayed by generating germline clones of the genotype shown in 
females crossed by YSX · YL, v f B/0 ; C(4)RM, ci ey
R/0 males.
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Our design contains several advantages over a previously published 
FLP/FRT-based screen of chromosome arm 3L carried out specifically 
for the discovery of meiotic mutants.5,18 Similar to our screen, the 
FLP/FRT system was used to generate clones of gamma-irradiated 
chromosomes 3L in females that were crossed to C(2)EN-bearing 
males. However, the screen in this study utilizes molecular poly-
morphism mapping to rapidly map and identify the gene affected. 
Also, in the 3L screen, germline clones were generated in a wild-type 
background, so nonrecombinant and twin spot clones were not 
suppressed, whereas the FLP-DFS technique in our screen prevents 
non-mutant cells from competing with the mutant clones during 
oogenesis. Finally, by using EMS rather than gamma irradiation to 
induce mutations, we are more likely to avoid the generation of chro-
mosome rearrangements, which can mimic true meiotic mutations.
Doc element‑induced mutations. Generally, EMS mutagenesis 
is expected to produce point mutations.13,60 Surprisingly, five of the 
nine mutations that have been identified at the molecular level were 
associated with new insertions of Doc retrotransposons, one was a 
small deletion, and only three were point mutations. In two cases 
(c(2)M8C and c(2)M10C), Doc elements were inserted into protein 
coding sequence of the meiotic gene affected, and in a third case 
(conaA12), the insertion occurred in the 3' untranslated region. The 
remaining two cases (aldA15 and aldB8) were Doc insertions that affect 
the ald gene despite being located in a neighboring gene (CG18212) 
over 1.5 kb away, possibly through the cis-inactivation of ald in the 
female germline.22
Doc elements are approximately 4.7 kb long non-LTR retrotrans-
posons that have been estimated to be present in 20 to 55 copies 
in the genomes of Drosophila stocks.42,43,61,62 One possible cause 
for the recovery of several Doc element insertions in the screen is 
the fortuitous use of stocks in which Doc elements were unstable. 
The transposition of Doc elements within Drosophila stocks has 
been documented63 and if transposition was occurring within the 
stocks used in the mutagenesis, the subsequent screen could have 
selected for new Doc insertions associated with a meiotic phenotype. 
DNA damage induced by EMS exposure could also have promoted 
 transposition by leading to single-strand nicks in chromosomal 
DNA, which have been suggested to serve as sites of non-LTR 
 retrotransposon insertion.64
The limits of the screen. While our finding that only two of 
eleven new mutants were lethal or semi-lethal does not support the 
idea that a substantial fraction of meiotic mutants have been missed 
in previous screens as a consequence of post-zygotic lethality, our 
results demonstrate that this screen allowed us to identify meiotic 
mutants that were either lethal on their own (such as ald C3 and 
aldB4), as well as mutants on chromosomes that carried unrelated 
lethal mutations (for example, tremF9). However, we note that 
a number of mutants with strong meiotic defects, such as nhk1, 
grauzone and cortex have been identified by cytological analysis of 
female sterile mutants,65,66 thus the possibility remains that mutants 
may have been lost as female steriles. It is important to note that 
certain types of female sterile mutants would have escaped recovery, 
including any mutant that defined a function that is also required 
within the female germline to produce viable eggs. Such mutations 
might have indicated genes involved in early cystoblast divisions, 
oocyte differentiation or growth, or that are required for early 
 embryonic survival. To identify mutants that are also essential for 
the early stages of oogenesis, we suspect that additional methods 
will likely be required, such as screening for dominant enhancers 
of known meiotic mutants or screening for conditional (i.e., 
 temperature-sensitive) meiotic mutations.
The mutants we didn’t get. Although five of the 11 mutants 
identified in this study define at least four new meiotic genes, it is 
curious that we did not recover mutants in other well characterized 
meiotic genes on chromosome 3R, such as c(3)G, rec, and ncd. We 
do, however, note that a previous P element screen for new autosomal 
meiotic mutants also failed to identify novel mutants in either c(3)G 
or rec.4 Both the absence of new mutants in these genes from either 
screen and the finding of numerous previously unidentified meiotic 
loci suggest that the screens are far from saturating and that many new 
meiotic mutants remain to be identified. It is obviously imperative to 
extend this study to the remaining sixty percent of the genome (X, 
2R, 3L). This can be done with relative ease because of the availability 
of chromosomes bearing FRT sites, corresponding dominant female 
sterile P{ovoD1‑18} insertions, and the multitude of SNP and InDel 
polymorphisms that have now been characterized.19,20
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